Validation of 6-mercaptopurine and 6-thioguanine in dried blood spot by ultra performance liquid chromatography-tandem mass spectrometry

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Objective: This study aimed to obtain an optimal and validated method of analyzing 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG) simultaneously in dried blood spot samples using ultra high-performance liquid chromatography-tandem mass spectrometry. Method: Separation was performed with a 1.7-µm amide column, which had a mobile phase with a flow rate of 0.2 mL/min and comprised 0.2% formic acid in water, 0.1% formic acid in acetonitrile, and methanol with a gradient elution. Detection was performed using Waters Xevo TQD. Result: This method was linear with a range of 25.1000 ng/mL for 6-MP and 6-TG, with consecutive r values of ≥0.996 and ≥0.995, respectively. The intra- and inter-day % difference value and coefficient of variation for the accuracy and precision were not more than 15% and 20%, respectively, at a concentration lower limit of quantitation. Conclusion: This method fulfilled the requirements of the European Medicines Agency guideline for validation.

Cite

CITATION STYLE

APA

Harahap, Y., Astrini, C. R., & Suryadi, H. (2018). Validation of 6-mercaptopurine and 6-thioguanine in dried blood spot by ultra performance liquid chromatography-tandem mass spectrometry. International Journal of Applied Pharmaceutics, 10(Special Issue 1), 412–415. https://doi.org/10.22159/ijap.2018.v10s1.91

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free